Cargando…
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
Carbonic anhydrase (CA) IX has emerged as a promising target for cancer therapy. It is highly upregulated in hypoxic regions and mediates pH regulation critical for tumor cell survival as well as extracellular acidification of the tumor microenvironment, which promotes tumor aggressiveness via vario...
Autores principales: | Riemann, Anne, Güttler, Antje, Haupt, Verena, Wichmann, Henri, Reime, Sarah, Bache, Matthias, Vordermark, Dirk, Thews, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844713/ https://www.ncbi.nlm.nih.gov/pubmed/28631600 http://dx.doi.org/10.3727/096504017X14965111926391 |
Ejemplares similares
-
Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018) -
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
por: Iikuni, Shimpei, et al.
Publicado: (2020) -
Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells
por: Riemann, Anne, et al.
Publicado: (2019) -
Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells
por: Güttler, Antje, et al.
Publicado: (2021) -
Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
por: Bache, Matthias, et al.
Publicado: (2023)